KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Liabilities and Shareholders Equity (2017 - 2025)

Cigna's Liabilities and Shareholders Equity history spans 8 years, with the latest figure at $157.9 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 1.31% year-over-year to $157.9 billion; the TTM value through Dec 2025 reached $618.1 billion, up 31.81%, while the annual FY2025 figure was $157.9 billion, 1.31% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $157.9 billion at Cigna, roughly flat from $157.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $157.9 billion in Q3 2025 and bottomed at $143.9 billion in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $152.6 billion (2022), against an average of $152.4 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity decreased 7.1% in 2022 before it rose 6.17% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $154.9 billion in 2021, then fell by 7.1% to $143.9 billion in 2022, then grew by 6.17% to $152.8 billion in 2023, then rose by 2.04% to $155.9 billion in 2024, then rose by 1.31% to $157.9 billion in 2025.
  • Per Business Quant, the three most recent readings for CI's Liabilities and Shareholders Equity are $157.9 billion (Q4 2025), $157.9 billion (Q3 2025), and $151.7 billion (Q2 2025).